info@healthcostinstitute.org

mediA@healthcostinstitute.org

  • X
  • LinkedIn
  • Link
Search
Health Care Cost Institute
  • Home
  • About US
    • HCCI Data
    • HCCI Staff
      • CEO
      • Careers
    • Financial Statements
    • Governing Board 
  • Data Tools
    • Data Access Hub
    • HCCI Vitals
    • Healthprices.org
    • HMI
    • DataNerd
  • Research
    • Original Reports
    • HCCUR
    • Vitals HMI
Search
News

Kaiser Health News: California Rx: State May Dive Into Generic Drug Market

Angela Hart and Samantha Young
September 1, 2020

HCCI’s research on insulin prices was cited by Kaiser Health News.  

From the article: 

“Patients who need insulin have faced huge cost spikes. A 2019 report by the Health Care Cost Institute concluded that average prices for insulin doubled from 2012 to 2016.”

Kaiser Health News: California Rx: State May Dive Into Generic Drug Market
California Rx: State May Dive Into Generic Drug Market | Kaiser Health News

California could become the first state to develop its own line of generic drugs under a bill approved Monday by the legislature. The measure heads to Gov. Gavin Newsom for consideration.

https://khn.org/news/california-rx-state-may-dive-into-generic-drug-market/

Share this post

  • Facebook
  • X
  • LinkedIn
Topics: Insulin Kaiser Health News

Enhance your research using customized data analysis

Are you interested in a specific health care topic? HCCI can use our commercial and government data resources and unique analytic experience to help you. Just reach out!

Partner with us

About

We are a mission-driven, independent, nonprofit organization situated at the nexus of data, analytics, and action.

Contact

1100 G Street NW, Suite 600
Washington DC, 20005

info@healthcostinstitute.org
media@healthcostinstitute.org

Research

HCCI Publications
Research Resources

Data

Data Access Hub
Data Tools

Quick Links

Partner with HCCI
HCCI Newsletter
Careers

  • LinkedIn
  • X
  • Link
  • Bluesky

© 2025 Health Care Cost Institute Inc.
Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License

Scroll to Top